European Drug Report 2017
European Drug Report 2017
What do the latest data tell us about the European drug market? What are the new trends in drug use among European adults and school students? What are the harms associated with drug use and what is being done to counter them? These and other questions are explored in the 2017 European Drug Report, our annual overview of the drug situation in Europe. #EDR2017
Embargoed copies of the EDR 2017 will be available on request via e-mail: press@emcdda.europa.eu
Press contacts
For media queries before 6 June, please contact:
Kathryn Robertson or Maria José Louro
Tel. (351) 211 21 02 40/00
From 6–8 June, calls from the media will be dispatched (according to subject areas & languages) to our frontline team of experts. Please contact the following number: Alessandra Bo — Tel. (351) 211 21 03 17/ 02 00
Country-specific queries
Helpdesks at national focal points (PDF)
European Drug Report
European Drug Report 2017: Trends and Developments
Country Drug Reports
Country Drug Reports are a new product and present summaries of national drug phenomena. Developed by the EMCDDA, in cooperation with the Reitox national focal points, these graphic-rich reports cover: drug use and public health problems; drug policy and responses and drug supply. Download them below.
Press material
Speeches
- Speech by EMCDDA Director, Alexis Goosdeel
- Speech by Laura d'Arrigo, Chair of the EMCDDA Management Board
- Remarks by Commissioner Avramopoulos at the Launch of the European Drug Report 2017
Promotional material
Audiovisual material
Motion graphics
European Drug Report 2017: Trends and Developments in Europe's drug situation
Other audiovisual material
Other material will be added here as it becomes available.
National launches
Greece
Date of event: 6 June
Venue: Athens
Type: Press conference
Auspices: National drug coordinator
EMCDDA staff present: No
Cyprus
Date of event: 6 June
Venue: Nicosia
Type: Press conference
Auspices: Minister of Health
EMCDDA staff present: Eoghan Quigley, Scientific analyst/writer — drug policy
Latvia
Date of event: 6 September
Venue: Rīga
Type: Conference and press conference
Auspices: Centre for Disease Prevention and Control, Ministry of Health (national focal point)
EMCDDA staff present: To be confirmed
Lithuania
Date of event: 6 June
Venue: Vilnius
Type: Conference/seminar
Auspices: Drug, Tobacco and Alcohol Department
EMCDDA staff present: Gregor Burkhart, Principal scientific analyst — prevention
Poland
Date of event: October/November
Venue: Warsaw
Type: Conference/seminar
Auspices: National Bureau for Drug Prevention
EMCDDA staff present: To be confirmed
Portugal
Date of event: November/December
Venue: Lisbon
Type: Conference and press conference
Auspices: National Parliament and SICAD (national focal point)
EMCDDA staff present: To be confirmed
Romania
Date of event: 6 June
Venue: Bucharest
Type: Roundtable and press conference
Auspices: Romanian Anti-drug Agency (national focal point)
EMCDDA staff present: Gonçalo Felgueiras e Sousa, Head of unit, Reitox and external partners cooperation
Slovenia
Date of event: November
Venue: Ljubljana
Type: Annual National Prevention Conference
Auspices: Ministry of Health and National Institute of Public Health (national focal point)
EMCDDA staff present: To be confirmed
Slovakia
Date of event: 6 June
Venue: Bratislava
Type: Conference and press conference
Auspices: Ministry of Health
EMCDDA staff present: Teodora Groshkova, Scientific analyst — drug supply indicators
Norway
Date of event: 6 June
Venue: Oslo
Type: Conference/seminar
Auspices: Ministry of Health and Care Services/Public Health Institute (national focal point)
EMCDDA staff present: Brendan Hughes, Principal scientific analyst — national legislation, European Legal Database on Drugs (ELDD)